nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—breast cancer	0.349	1	CbGaD
Fidaxomicin—ABCB1—Toremifene—breast cancer	0.101	0.223	CbGbCtD
Fidaxomicin—ABCB1—Lapatinib—breast cancer	0.0739	0.162	CbGbCtD
Fidaxomicin—ABCB1—Vinorelbine—breast cancer	0.041	0.0901	CbGbCtD
Fidaxomicin—ABCB1—Tamoxifen—breast cancer	0.037	0.0813	CbGbCtD
Fidaxomicin—ABCB1—Mitoxantrone—breast cancer	0.0361	0.0793	CbGbCtD
Fidaxomicin—ABCB1—Gemcitabine—breast cancer	0.0319	0.0701	CbGbCtD
Fidaxomicin—ABCB1—Paclitaxel—breast cancer	0.0288	0.0633	CbGbCtD
Fidaxomicin—ABCB1—Irinotecan—breast cancer	0.0284	0.0624	CbGbCtD
Fidaxomicin—ABCB1—Vinblastine—breast cancer	0.0253	0.0555	CbGbCtD
Fidaxomicin—ABCB1—Docetaxel—breast cancer	0.0208	0.0458	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—breast cancer	0.0155	0.0341	CbGbCtD
Fidaxomicin—ABCB1—Methotrexate—breast cancer	0.015	0.033	CbGbCtD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—SLCO1B1—breast cancer	0.00089	0.0805	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transmembrane transport—ABCG2—breast cancer	0.000657	0.0595	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PEX14—breast cancer	0.000545	0.0493	CbGpPWpGaD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—SLCO1B1—breast cancer	0.000487	0.044	CbGpPWpGaD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—CYP2D6—breast cancer	0.000395	0.0357	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transport and metabolism—ABCG2—breast cancer	0.000378	0.0342	CbGpPWpGaD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—breast cancer	0.000348	0.0315	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SLC4A7—breast cancer	0.000286	0.0259	CbGpPWpGaD
Fidaxomicin—Flatulence—Paclitaxel—breast cancer	0.000226	0.00122	CcSEcCtD
Fidaxomicin—Pruritus—Melphalan—breast cancer	0.000225	0.00122	CcSEcCtD
Fidaxomicin—Nervous system disorder—Irinotecan—breast cancer	0.000225	0.00121	CcSEcCtD
Fidaxomicin—Dysgeusia—Paclitaxel—breast cancer	0.000225	0.00121	CcSEcCtD
Fidaxomicin—Skin disorder—Mitoxantrone—breast cancer	0.000223	0.0012	CcSEcCtD
Fidaxomicin—Dizziness—Vinblastine—breast cancer	0.000221	0.00119	CcSEcCtD
Fidaxomicin—Abdominal pain—Vinorelbine—breast cancer	0.00022	0.00119	CcSEcCtD
Fidaxomicin—Pruritus—Goserelin—breast cancer	0.00022	0.00119	CcSEcCtD
Fidaxomicin—Nervous system disorder—Gemcitabine—breast cancer	0.000219	0.00118	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—breast cancer	0.000218	0.00117	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Thiotepa—breast cancer	0.000217	0.00117	CcSEcCtD
Fidaxomicin—Skin disorder—Gemcitabine—breast cancer	0.000217	0.00117	CcSEcCtD
Fidaxomicin—Nausea—Chlorambucil—breast cancer	0.000217	0.00117	CcSEcCtD
Fidaxomicin—Nervous system disorder—Fluorouracil—breast cancer	0.000215	0.00116	CcSEcCtD
Fidaxomicin—Dizziness—Tamoxifen—breast cancer	0.000215	0.00116	CcSEcCtD
Fidaxomicin—Vomiting—Vinblastine—breast cancer	0.000213	0.00115	CcSEcCtD
Fidaxomicin—Anaemia—Paclitaxel—breast cancer	0.000212	0.00114	CcSEcCtD
Fidaxomicin—Abdominal pain—Thiotepa—breast cancer	0.00021	0.00113	CcSEcCtD
Fidaxomicin—Headache—Vinblastine—breast cancer	0.00021	0.00113	CcSEcCtD
Fidaxomicin—Angioedema—Paclitaxel—breast cancer	0.000209	0.00113	CcSEcCtD
Fidaxomicin—Vomiting—Tamoxifen—breast cancer	0.000207	0.00112	CcSEcCtD
Fidaxomicin—Dizziness—Goserelin—breast cancer	0.000205	0.00111	CcSEcCtD
Fidaxomicin—Rash—Tamoxifen—breast cancer	0.000205	0.00111	CcSEcCtD
Fidaxomicin—Hypersensitivity—Vinorelbine—breast cancer	0.000205	0.00111	CcSEcCtD
Fidaxomicin—Dermatitis—Tamoxifen—breast cancer	0.000205	0.00111	CcSEcCtD
Fidaxomicin—Dyspnoea—Irinotecan—breast cancer	0.000205	0.0011	CcSEcCtD
Fidaxomicin—Dyspnoea—Mitoxantrone—breast cancer	0.000205	0.0011	CcSEcCtD
Fidaxomicin—Headache—Tamoxifen—breast cancer	0.000204	0.0011	CcSEcCtD
Fidaxomicin—Vomiting—Melphalan—breast cancer	0.000202	0.00109	CcSEcCtD
Fidaxomicin—Dyspepsia—Mitoxantrone—breast cancer	0.000202	0.00109	CcSEcCtD
Fidaxomicin—Dyspepsia—Irinotecan—breast cancer	0.000202	0.00109	CcSEcCtD
Fidaxomicin—Immune system disorder—Docetaxel—breast cancer	0.000202	0.00109	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000201	0.00109	CcSEcCtD
Fidaxomicin—Rash—Melphalan—breast cancer	0.000201	0.00108	CcSEcCtD
Fidaxomicin—Dermatitis—Melphalan—breast cancer	0.000201	0.00108	CcSEcCtD
Fidaxomicin—Decreased appetite—Mitoxantrone—breast cancer	0.000199	0.00108	CcSEcCtD
Fidaxomicin—Decreased appetite—Irinotecan—breast cancer	0.000199	0.00108	CcSEcCtD
Fidaxomicin—Dyspnoea—Gemcitabine—breast cancer	0.000199	0.00108	CcSEcCtD
Fidaxomicin—Nausea—Vinblastine—breast cancer	0.000199	0.00107	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000198	0.00107	CcSEcCtD
Fidaxomicin—Vomiting—Goserelin—breast cancer	0.000197	0.00107	CcSEcCtD
Fidaxomicin—Pruritus—Vinorelbine—breast cancer	0.000197	0.00106	CcSEcCtD
Fidaxomicin—Constipation—Mitoxantrone—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—Constipation—Irinotecan—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—Dyspnoea—Fluorouracil—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—Rash—Goserelin—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—Hypersensitivity—Thiotepa—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—Dermatitis—Goserelin—breast cancer	0.000196	0.00106	CcSEcCtD
Fidaxomicin—ABCB1—ABC-family proteins mediated transport—ABCC1—breast cancer	0.000196	0.0177	CbGpPWpGaD
Fidaxomicin—Immune system disorder—Capecitabine—breast cancer	0.000195	0.00105	CcSEcCtD
Fidaxomicin—Headache—Goserelin—breast cancer	0.000195	0.00105	CcSEcCtD
Fidaxomicin—Malnutrition—Docetaxel—breast cancer	0.000194	0.00105	CcSEcCtD
Fidaxomicin—Decreased appetite—Gemcitabine—breast cancer	0.000194	0.00105	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000194	0.00105	CcSEcCtD
Fidaxomicin—Dyspepsia—Fluorouracil—breast cancer	0.000193	0.00104	CcSEcCtD
Fidaxomicin—Nausea—Tamoxifen—breast cancer	0.000193	0.00104	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000193	0.00104	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000192	0.00104	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000191	0.0173	CbGpPWpGaD
Fidaxomicin—Constipation—Gemcitabine—breast cancer	0.000191	0.00103	CcSEcCtD
Fidaxomicin—Decreased appetite—Fluorouracil—breast cancer	0.000191	0.00103	CcSEcCtD
Fidaxomicin—Dry mouth—Paclitaxel—breast cancer	0.000191	0.00103	CcSEcCtD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—breast cancer	0.00019	0.0172	CbGpPWpGaD
Fidaxomicin—Dysgeusia—Docetaxel—breast cancer	0.00019	0.00103	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00019	0.00102	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—breast cancer	0.000189	0.00102	CcSEcCtD
Fidaxomicin—Nausea—Melphalan—breast cancer	0.000189	0.00102	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000189	0.0171	CbGpPWpGaD
Fidaxomicin—Malnutrition—Capecitabine—breast cancer	0.000188	0.00102	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—breast cancer	0.000188	0.00102	CcSEcCtD
Fidaxomicin—Neutropenia—Methotrexate—breast cancer	0.000188	0.00101	CcSEcCtD
Fidaxomicin—Pruritus—Thiotepa—breast cancer	0.000188	0.00101	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Irinotecan—breast cancer	0.000188	0.00101	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000188	0.00101	CcSEcCtD
Fidaxomicin—Flatulence—Capecitabine—breast cancer	0.000185	0.001	CcSEcCtD
Fidaxomicin—Nausea—Goserelin—breast cancer	0.000184	0.000996	CcSEcCtD
Fidaxomicin—Dysgeusia—Capecitabine—breast cancer	0.000184	0.000994	CcSEcCtD
Fidaxomicin—Dizziness—Vinorelbine—breast cancer	0.000184	0.000993	CcSEcCtD
Fidaxomicin—Nervous system disorder—Paclitaxel—breast cancer	0.000183	0.00099	CcSEcCtD
Fidaxomicin—Skin disorder—Paclitaxel—breast cancer	0.000182	0.000981	CcSEcCtD
Fidaxomicin—Abdominal pain—Mitoxantrone—breast cancer	0.000181	0.000979	CcSEcCtD
Fidaxomicin—Abdominal pain—Irinotecan—breast cancer	0.000181	0.000979	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—breast cancer	0.00018	0.0163	CbGpPWpGaD
Fidaxomicin—Anaemia—Docetaxel—breast cancer	0.00018	0.000969	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000178	0.000958	CcSEcCtD
Fidaxomicin—Vomiting—Vinorelbine—breast cancer	0.000177	0.000954	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—breast cancer	0.000176	0.000949	CcSEcCtD
Fidaxomicin—Dizziness—Thiotepa—breast cancer	0.000176	0.000948	CcSEcCtD
Fidaxomicin—Rash—Vinorelbine—breast cancer	0.000175	0.000947	CcSEcCtD
Fidaxomicin—Dermatitis—Vinorelbine—breast cancer	0.000175	0.000946	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—breast cancer	0.000175	0.000946	CcSEcCtD
Fidaxomicin—Headache—Vinorelbine—breast cancer	0.000174	0.00094	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—breast cancer	0.000174	0.000939	CcSEcCtD
Fidaxomicin—Anaemia—Capecitabine—breast cancer	0.000174	0.000938	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—breast cancer	0.00017	0.000916	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Methotrexate—breast cancer	0.00017	0.000915	CcSEcCtD
Fidaxomicin—Hypersensitivity—Mitoxantrone—breast cancer	0.000169	0.000912	CcSEcCtD
Fidaxomicin—Hypersensitivity—Irinotecan—breast cancer	0.000169	0.000912	CcSEcCtD
Fidaxomicin—Vomiting—Thiotepa—breast cancer	0.000169	0.000912	CcSEcCtD
Fidaxomicin—Rash—Thiotepa—breast cancer	0.000168	0.000904	CcSEcCtD
Fidaxomicin—Dermatitis—Thiotepa—breast cancer	0.000167	0.000903	CcSEcCtD
Fidaxomicin—Dyspnoea—Paclitaxel—breast cancer	0.000167	0.0009	CcSEcCtD
Fidaxomicin—Headache—Thiotepa—breast cancer	0.000166	0.000898	CcSEcCtD
Fidaxomicin—Nausea—Vinorelbine—breast cancer	0.000165	0.000892	CcSEcCtD
Fidaxomicin—Dyspepsia—Paclitaxel—breast cancer	0.000165	0.000889	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000164	0.000887	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—breast cancer	0.000163	0.000878	CcSEcCtD
Fidaxomicin—Decreased appetite—Paclitaxel—breast cancer	0.000163	0.000878	CcSEcCtD
Fidaxomicin—Hypersensitivity—Fluorouracil—breast cancer	0.000162	0.000874	CcSEcCtD
Fidaxomicin—Dry mouth—Docetaxel—breast cancer	0.000162	0.000873	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000162	0.000872	CcSEcCtD
Fidaxomicin—Constipation—Paclitaxel—breast cancer	0.00016	0.000863	CcSEcCtD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—breast cancer	0.000159	0.0144	CbGpPWpGaD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000159	0.000858	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—breast cancer	0.000159	0.000856	CcSEcCtD
Fidaxomicin—Pruritus—Gemcitabine—breast cancer	0.000158	0.000853	CcSEcCtD
Fidaxomicin—Nausea—Thiotepa—breast cancer	0.000158	0.000852	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—breast cancer	0.000157	0.000847	CcSEcCtD
Fidaxomicin—Dry mouth—Capecitabine—breast cancer	0.000157	0.000845	CcSEcCtD
Fidaxomicin—Nervous system disorder—Docetaxel—breast cancer	0.000156	0.000839	CcSEcCtD
Fidaxomicin—Pruritus—Fluorouracil—breast cancer	0.000155	0.000839	CcSEcCtD
Fidaxomicin—Skin disorder—Docetaxel—breast cancer	0.000154	0.000831	CcSEcCtD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000154	0.0139	CbGpPWpGaD
Fidaxomicin—Gastrointestinal pain—Paclitaxel—breast cancer	0.000153	0.000826	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—breast cancer	0.000153	0.0138	CbGpPWpGaD
Fidaxomicin—Dizziness—Irinotecan—breast cancer	0.000152	0.000819	CcSEcCtD
Fidaxomicin—Nervous system disorder—Capecitabine—breast cancer	0.000151	0.000813	CcSEcCtD
Fidaxomicin—Skin disorder—Capecitabine—breast cancer	0.000149	0.000805	CcSEcCtD
Fidaxomicin—Abdominal pain—Paclitaxel—breast cancer	0.000148	0.000798	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—breast cancer	0.000147	0.000792	CcSEcCtD
Fidaxomicin—Vomiting—Mitoxantrone—breast cancer	0.000146	0.000787	CcSEcCtD
Fidaxomicin—Vomiting—Irinotecan—breast cancer	0.000146	0.000787	CcSEcCtD
Fidaxomicin—Immune system disorder—Methotrexate—breast cancer	0.000145	0.000784	CcSEcCtD
Fidaxomicin—Dizziness—Fluorouracil—breast cancer	0.000145	0.000784	CcSEcCtD
Fidaxomicin—Rash—Mitoxantrone—breast cancer	0.000145	0.000781	CcSEcCtD
Fidaxomicin—Rash—Irinotecan—breast cancer	0.000145	0.000781	CcSEcCtD
Fidaxomicin—Dermatitis—Mitoxantrone—breast cancer	0.000145	0.00078	CcSEcCtD
Fidaxomicin—Dermatitis—Irinotecan—breast cancer	0.000145	0.00078	CcSEcCtD
Fidaxomicin—Headache—Mitoxantrone—breast cancer	0.000144	0.000776	CcSEcCtD
Fidaxomicin—Headache—Irinotecan—breast cancer	0.000144	0.000776	CcSEcCtD
Fidaxomicin—Vomiting—Gemcitabine—breast cancer	0.000142	0.000767	CcSEcCtD
Fidaxomicin—Dyspnoea—Docetaxel—breast cancer	0.000141	0.000763	CcSEcCtD
Fidaxomicin—Rash—Gemcitabine—breast cancer	0.000141	0.00076	CcSEcCtD
Fidaxomicin—Dermatitis—Gemcitabine—breast cancer	0.000141	0.00076	CcSEcCtD
Fidaxomicin—Malnutrition—Methotrexate—breast cancer	0.00014	0.000756	CcSEcCtD
Fidaxomicin—Headache—Gemcitabine—breast cancer	0.00014	0.000756	CcSEcCtD
Fidaxomicin—Vomiting—Fluorouracil—breast cancer	0.00014	0.000754	CcSEcCtD
Fidaxomicin—Dyspepsia—Docetaxel—breast cancer	0.00014	0.000753	CcSEcCtD
Fidaxomicin—Rash—Fluorouracil—breast cancer	0.000139	0.000748	CcSEcCtD
Fidaxomicin—Dermatitis—Fluorouracil—breast cancer	0.000138	0.000747	CcSEcCtD
Fidaxomicin—Decreased appetite—Docetaxel—breast cancer	0.000138	0.000744	CcSEcCtD
Fidaxomicin—Hypersensitivity—Paclitaxel—breast cancer	0.000138	0.000744	CcSEcCtD
Fidaxomicin—Headache—Fluorouracil—breast cancer	0.000138	0.000743	CcSEcCtD
Fidaxomicin—Dysgeusia—Methotrexate—breast cancer	0.000137	0.00074	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000137	0.000739	CcSEcCtD
Fidaxomicin—Dyspnoea—Capecitabine—breast cancer	0.000137	0.000739	CcSEcCtD
Fidaxomicin—Nausea—Irinotecan—breast cancer	0.000136	0.000735	CcSEcCtD
Fidaxomicin—Nausea—Mitoxantrone—breast cancer	0.000136	0.000735	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—breast cancer	0.000136	0.000734	CcSEcCtD
Fidaxomicin—Constipation—Docetaxel—breast cancer	0.000136	0.000732	CcSEcCtD
Fidaxomicin—Dyspepsia—Capecitabine—breast cancer	0.000135	0.000729	CcSEcCtD
Fidaxomicin—Decreased appetite—Capecitabine—breast cancer	0.000133	0.00072	CcSEcCtD
Fidaxomicin—Nausea—Gemcitabine—breast cancer	0.000133	0.000716	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000133	0.000715	CcSEcCtD
Fidaxomicin—Pruritus—Paclitaxel—breast cancer	0.000132	0.000714	CcSEcCtD
Fidaxomicin—Constipation—Capecitabine—breast cancer	0.000131	0.000709	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—breast cancer	0.000131	0.000707	CcSEcCtD
Fidaxomicin—Nausea—Fluorouracil—breast cancer	0.000131	0.000704	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Docetaxel—breast cancer	0.00013	0.0007	CcSEcCtD
Fidaxomicin—Anaemia—Methotrexate—breast cancer	0.000129	0.000699	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—breast cancer	0.000129	0.000697	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—breast cancer	0.000128	0.000693	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000128	0.0116	CbGpPWpGaD
Fidaxomicin—Immune system disorder—Doxorubicin—breast cancer	0.000126	0.000679	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Capecitabine—breast cancer	0.000126	0.000678	CcSEcCtD
Fidaxomicin—Abdominal pain—Docetaxel—breast cancer	0.000125	0.000677	CcSEcCtD
Fidaxomicin—Dizziness—Paclitaxel—breast cancer	0.000124	0.000668	CcSEcCtD
Fidaxomicin—Abdominal pain—Capecitabine—breast cancer	0.000121	0.000655	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—breast cancer	0.000121	0.000654	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—breast cancer	0.000121	0.000654	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—breast cancer	0.00012	0.0109	CbGpPWpGaD
Fidaxomicin—Flatulence—Doxorubicin—breast cancer	0.00012	0.000645	CcSEcCtD
Fidaxomicin—Vomiting—Paclitaxel—breast cancer	0.000119	0.000642	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—breast cancer	0.000119	0.000641	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000118	0.000639	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RB1CC1—breast cancer	0.000118	0.0107	CbGpPWpGaD
Fidaxomicin—Rash—Paclitaxel—breast cancer	0.000118	0.000637	CcSEcCtD
Fidaxomicin—Dermatitis—Paclitaxel—breast cancer	0.000118	0.000636	CcSEcCtD
Fidaxomicin—Headache—Paclitaxel—breast cancer	0.000117	0.000633	CcSEcCtD
Fidaxomicin—Hypersensitivity—Docetaxel—breast cancer	0.000117	0.000631	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—breast cancer	0.000115	0.0104	CbGpPWpGaD
Fidaxomicin—Hypersensitivity—Capecitabine—breast cancer	0.000113	0.000611	CcSEcCtD
Fidaxomicin—Pruritus—Docetaxel—breast cancer	0.000112	0.000606	CcSEcCtD
Fidaxomicin—Nervous system disorder—Methotrexate—breast cancer	0.000112	0.000605	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—breast cancer	0.000112	0.000605	CcSEcCtD
Fidaxomicin—Nausea—Paclitaxel—breast cancer	0.000111	0.0006	CcSEcCtD
Fidaxomicin—Skin disorder—Methotrexate—breast cancer	0.000111	0.000599	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000111	0.000598	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.000111	0.01	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CA9—breast cancer	0.00011	0.00996	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—breast cancer	0.000109	0.00989	CbGpPWpGaD
Fidaxomicin—Dry mouth—Epirubicin—breast cancer	0.000109	0.000589	CcSEcCtD
Fidaxomicin—Pruritus—Capecitabine—breast cancer	0.000109	0.000586	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000108	0.00974	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—breast cancer	0.000106	0.00958	CbGpPWpGaD
Fidaxomicin—Nervous system disorder—Epirubicin—breast cancer	0.000105	0.000566	CcSEcCtD
Fidaxomicin—Dizziness—Docetaxel—breast cancer	0.000105	0.000566	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—breast cancer	0.000104	0.000561	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000103	0.000553	CcSEcCtD
Fidaxomicin—Dyspnoea—Methotrexate—breast cancer	0.000102	0.00055	CcSEcCtD
Fidaxomicin—Dizziness—Capecitabine—breast cancer	0.000102	0.000548	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—breast cancer	0.000101	0.000545	CcSEcCtD
Fidaxomicin—Vomiting—Docetaxel—breast cancer	0.000101	0.000544	CcSEcCtD
Fidaxomicin—Dyspepsia—Methotrexate—breast cancer	0.000101	0.000543	CcSEcCtD
Fidaxomicin—Rash—Docetaxel—breast cancer	0.0001	0.00054	CcSEcCtD
Fidaxomicin—Dermatitis—Docetaxel—breast cancer	9.99e-05	0.000539	CcSEcCtD
Fidaxomicin—Decreased appetite—Methotrexate—breast cancer	9.94e-05	0.000536	CcSEcCtD
Fidaxomicin—Headache—Docetaxel—breast cancer	9.94e-05	0.000536	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Methotrexate—breast cancer	9.87e-05	0.000533	CcSEcCtD
Fidaxomicin—Vomiting—Capecitabine—breast cancer	9.76e-05	0.000527	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—breast cancer	9.71e-05	0.000524	CcSEcCtD
Fidaxomicin—Rash—Capecitabine—breast cancer	9.68e-05	0.000522	CcSEcCtD
Fidaxomicin—Dermatitis—Capecitabine—breast cancer	9.67e-05	0.000522	CcSEcCtD
Fidaxomicin—Headache—Capecitabine—breast cancer	9.62e-05	0.000519	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—breast cancer	9.61e-05	0.000519	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—breast cancer	9.54e-05	0.000515	CcSEcCtD
Fidaxomicin—Nausea—Docetaxel—breast cancer	9.42e-05	0.000508	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—breast cancer	9.42e-05	0.000508	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Methotrexate—breast cancer	9.35e-05	0.000504	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—breast cancer	9.3e-05	0.000502	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—breast cancer	9.24e-05	0.000498	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—breast cancer	9.15e-05	0.000494	CcSEcCtD
Fidaxomicin—Nausea—Capecitabine—breast cancer	9.12e-05	0.000492	CcSEcCtD
Fidaxomicin—Abdominal pain—Methotrexate—breast cancer	9.04e-05	0.000488	CcSEcCtD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—breast cancer	8.96e-05	0.00811	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—ALDOA—breast cancer	8.84e-05	0.00799	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	8.83e-05	0.00799	CbGpPWpGaD
Fidaxomicin—Dyspnoea—Doxorubicin—breast cancer	8.82e-05	0.000476	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—breast cancer	8.75e-05	0.000472	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—breast cancer	8.71e-05	0.00047	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—breast cancer	8.6e-05	0.000464	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—breast cancer	8.55e-05	0.000461	CcSEcCtD
Fidaxomicin—Constipation—Doxorubicin—breast cancer	8.46e-05	0.000457	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—breast cancer	8.46e-05	0.000456	CcSEcCtD
Fidaxomicin—Hypersensitivity—Methotrexate—breast cancer	8.42e-05	0.000454	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—breast cancer	8.34e-05	0.00755	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—FOXP3—breast cancer	8.18e-05	0.0074	CbGpPWpGaD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—breast cancer	8.09e-05	0.000437	CcSEcCtD
Fidaxomicin—Pruritus—Methotrexate—breast cancer	8.09e-05	0.000436	CcSEcCtD
Fidaxomicin—Hypersensitivity—Epirubicin—breast cancer	7.88e-05	0.000425	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—breast cancer	7.82e-05	0.000422	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—breast cancer	7.62e-05	0.00689	CbGpPWpGaD
Fidaxomicin—Pruritus—Epirubicin—breast cancer	7.57e-05	0.000408	CcSEcCtD
Fidaxomicin—Dizziness—Methotrexate—breast cancer	7.56e-05	0.000408	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—ENO1—breast cancer	7.44e-05	0.00673	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—TFRC—breast cancer	7.44e-05	0.00673	CbGpPWpGaD
Fidaxomicin—Hypersensitivity—Doxorubicin—breast cancer	7.29e-05	0.000394	CcSEcCtD
Fidaxomicin—Vomiting—Methotrexate—breast cancer	7.27e-05	0.000392	CcSEcCtD
Fidaxomicin—Rash—Methotrexate—breast cancer	7.21e-05	0.000389	CcSEcCtD
Fidaxomicin—Dermatitis—Methotrexate—breast cancer	7.2e-05	0.000389	CcSEcCtD
Fidaxomicin—Headache—Methotrexate—breast cancer	7.16e-05	0.000386	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NCOA2—breast cancer	7.16e-05	0.00648	CbGpPWpGaD
Fidaxomicin—Dizziness—Epirubicin—breast cancer	7.07e-05	0.000382	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—breast cancer	7e-05	0.000378	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—GZMB—breast cancer	7e-05	0.00633	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—breast cancer	6.82e-05	0.00617	CbGpPWpGaD
Fidaxomicin—Vomiting—Epirubicin—breast cancer	6.8e-05	0.000367	CcSEcCtD
Fidaxomicin—Nausea—Methotrexate—breast cancer	6.79e-05	0.000366	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—breast cancer	6.74e-05	0.000364	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—breast cancer	6.74e-05	0.000364	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—breast cancer	6.7e-05	0.000362	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—breast cancer	6.67e-05	0.00603	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—breast cancer	6.67e-05	0.00603	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—breast cancer	6.6e-05	0.00597	CbGpPWpGaD
Fidaxomicin—Dizziness—Doxorubicin—breast cancer	6.55e-05	0.000353	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CASP7—breast cancer	6.41e-05	0.0058	CbGpPWpGaD
Fidaxomicin—Nausea—Epirubicin—breast cancer	6.35e-05	0.000343	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—breast cancer	6.29e-05	0.00034	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—breast cancer	6.24e-05	0.000337	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—breast cancer	6.24e-05	0.000336	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—breast cancer	6.2e-05	0.000335	CcSEcCtD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NCOA1—breast cancer	6.03e-05	0.00546	CbGpPWpGaD
Fidaxomicin—Nausea—Doxorubicin—breast cancer	5.88e-05	0.000317	CcSEcCtD
Fidaxomicin—ABCB1—Allograft Rejection—CXCL12—breast cancer	5.78e-05	0.00523	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CD40—breast cancer	5.71e-05	0.00517	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CTLA4—breast cancer	5.63e-05	0.00509	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—breast cancer	5.53e-05	0.00501	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—breast cancer	5.43e-05	0.00491	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—breast cancer	5.43e-05	0.00491	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—AGTR1—breast cancer	5.22e-05	0.00473	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—breast cancer	5.21e-05	0.00471	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—breast cancer	4.76e-05	0.00431	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	4.71e-05	0.00426	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—breast cancer	4.59e-05	0.00415	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—TERT—breast cancer	4.46e-05	0.00403	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—breast cancer	4.26e-05	0.00385	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC28A1—breast cancer	4.18e-05	0.00378	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—LEP—breast cancer	4.16e-05	0.00376	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	4e-05	0.00362	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	3.9e-05	0.00353	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NOS2—breast cancer	3.88e-05	0.00351	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC2A10—breast cancer	3.83e-05	0.00346	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC4A7—breast cancer	3.83e-05	0.00346	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	3.64e-05	0.00329	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—FOS—breast cancer	3.58e-05	0.00324	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	3.5e-05	0.00316	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	3.48e-05	0.00314	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—breast cancer	3.43e-05	0.0031	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	3.39e-05	0.00307	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—breast cancer	3.26e-05	0.00295	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—breast cancer	3.18e-05	0.00287	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—COX11—breast cancer	3.17e-05	0.00287	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC39A7—breast cancer	3.17e-05	0.00287	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	3.16e-05	0.00286	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	3.16e-05	0.00286	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CASP8—breast cancer	3.03e-05	0.00274	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	3.02e-05	0.00273	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC22A18—breast cancer	2.9e-05	0.00262	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	2.8e-05	0.00253	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	2.8e-05	0.00253	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC2A5—breast cancer	2.79e-05	0.00252	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	2.79e-05	0.00252	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	2.71e-05	0.00245	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—breast cancer	2.62e-05	0.00237	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	2.62e-05	0.00237	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IFNG—breast cancer	2.57e-05	0.00233	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—JUN—breast cancer	2.57e-05	0.00232	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	2.54e-05	0.0023	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	2.54e-05	0.0023	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—breast cancer	2.47e-05	0.00224	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC39A6—breast cancer	2.4e-05	0.00217	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CXCL8—breast cancer	2.39e-05	0.00217	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	2.39e-05	0.00216	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	2.3e-05	0.00208	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	2.3e-05	0.00208	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	2.3e-05	0.00208	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL1B—breast cancer	2.3e-05	0.00208	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CASP3—breast cancer	2.29e-05	0.00207	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL2—breast cancer	2.29e-05	0.00207	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	2.25e-05	0.00204	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—breast cancer	2.25e-05	0.00203	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	2.23e-05	0.00201	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	2.23e-05	0.00201	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	2.2e-05	0.00199	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	2.19e-05	0.00198	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	2.16e-05	0.00195	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	2.14e-05	0.00193	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	2.11e-05	0.0019	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	2.09e-05	0.00189	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	2.04e-05	0.00185	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—VEGFA—breast cancer	1.94e-05	0.00176	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	1.85e-05	0.00167	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	1.8e-05	0.00163	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SYNJ2—breast cancer	1.79e-05	0.00162	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—TGFB1—breast cancer	1.78e-05	0.00161	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	1.74e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	1.71e-05	0.00155	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	1.7e-05	0.00154	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	1.7e-05	0.00154	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—TNF—breast cancer	1.67e-05	0.00151	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NDUFS3—breast cancer	1.67e-05	0.00151	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	1.66e-05	0.0015	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	1.6e-05	0.00145	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	1.59e-05	0.00143	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CHST9—breast cancer	1.57e-05	0.00142	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.49e-05	0.00135	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—COX11—breast cancer	1.48e-05	0.00134	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.47e-05	0.00133	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.45e-05	0.00131	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	1.43e-05	0.0013	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.42e-05	0.00128	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CDA—breast cancer	1.36e-05	0.00123	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SHMT1—breast cancer	1.36e-05	0.00123	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLCO1B1—breast cancer	1.31e-05	0.00118	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC2A5—breast cancer	1.31e-05	0.00118	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.28e-05	0.00116	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.26e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—APRT—breast cancer	1.26e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.26e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.26e-05	0.00114	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.25e-05	0.00113	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.22e-05	0.0011	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.21e-05	0.0011	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ESRRA—breast cancer	1.19e-05	0.00107	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ANGPTL4—breast cancer	1.19e-05	0.00107	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.16e-05	0.00105	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.15e-05	0.00104	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.13e-05	0.00102	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HADHB—breast cancer	1.13e-05	0.00102	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GPI—breast cancer	1.13e-05	0.00102	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.12e-05	0.00101	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.1e-05	0.000995	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.1e-05	0.000993	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.09e-05	0.000986	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALDH1A1—breast cancer	1.07e-05	0.000971	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALDH7A1—breast cancer	1.07e-05	0.000971	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.06e-05	0.000963	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.06e-05	0.000961	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.04e-05	0.00094	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ADSL—breast cancer	1.03e-05	0.000931	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PHGDH—breast cancer	1.03e-05	0.000931	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NME1—breast cancer	1.03e-05	0.000931	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—FHL2—breast cancer	1.03e-05	0.000931	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UMPS—breast cancer	1.03e-05	0.000931	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.02e-05	0.000926	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HPSE—breast cancer	1.01e-05	0.000913	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—BRIP1—breast cancer	1.01e-05	0.000913	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—LDHB—breast cancer	1.01e-05	0.000913	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	9.98e-06	0.000902	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	9.85e-06	0.000891	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	9.59e-06	0.000868	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ABCC1—breast cancer	9.57e-06	0.000865	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HMMR—breast cancer	9.57e-06	0.000865	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA3—breast cancer	9.57e-06	0.000865	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PPARGC1B—breast cancer	9.27e-06	0.000838	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.21e-06	0.000833	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	9.08e-06	0.000821	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	8.83e-06	0.000798	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	8.81e-06	0.000797	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CA9—breast cancer	8.75e-06	0.000791	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA4—breast cancer	8.75e-06	0.000791	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	8.63e-06	0.000781	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA2—breast cancer	8.53e-06	0.000771	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GPX2—breast cancer	8.53e-06	0.000771	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SULT1A1—breast cancer	8.42e-06	0.000762	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GPX4—breast cancer	8.42e-06	0.000762	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—IDH1—breast cancer	8.23e-06	0.000744	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA1—breast cancer	8.23e-06	0.000744	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	8.22e-06	0.000744	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	8.16e-06	0.000738	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NAT2—breast cancer	8.14e-06	0.000736	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	7.49e-06	0.000678	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	7.25e-06	0.000656	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MED12—breast cancer	7.13e-06	0.000645	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—DPYD—breast cancer	7.13e-06	0.000645	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALDOA—breast cancer	7.02e-06	0.000635	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA3—breast cancer	6.82e-06	0.000617	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC2A2—breast cancer	6.77e-06	0.000612	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTR—breast cancer	6.63e-06	0.0006	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ABCG2—breast cancer	6.63e-06	0.0006	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CPT1A—breast cancer	6.63e-06	0.0006	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HPGDS—breast cancer	6.5e-06	0.000588	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HBA1—breast cancer	6.46e-06	0.000585	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTT1—breast cancer	6.31e-06	0.000571	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ACHE—breast cancer	6.31e-06	0.000571	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.12e-06	0.000554	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP17A1—breast cancer	5.97e-06	0.00054	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ENO1—breast cancer	5.91e-06	0.000535	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTGS1—breast cancer	5.91e-06	0.000535	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP2D6—breast cancer	5.8e-06	0.000524	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA2—breast cancer	5.69e-06	0.000515	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.53e-06	0.0005	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—FASN—breast cancer	5.52e-06	0.000499	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—BCHE—breast cancer	5.5e-06	0.000497	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC5A5—breast cancer	5.43e-06	0.000491	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NQO1—breast cancer	5.24e-06	0.000474	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC2A1—breast cancer	5.24e-06	0.000474	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP3A4—breast cancer	5.11e-06	0.000462	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP1B1—breast cancer	5.03e-06	0.000455	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5e-06	0.000452	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSP90AA1—breast cancer	4.93e-06	0.000446	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA1—breast cancer	4.79e-06	0.000434	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP19A1—breast cancer	4.73e-06	0.000427	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—STK11—breast cancer	4.73e-06	0.000427	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—COMT—breast cancer	4.39e-06	0.000397	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTP1—breast cancer	4.37e-06	0.000395	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HMOX1—breast cancer	4.31e-06	0.00039	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ITPR1—breast cancer	4.3e-06	0.000389	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TYMS—breast cancer	4.06e-06	0.000368	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTM1—breast cancer	4.02e-06	0.000363	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOR1—breast cancer	4.02e-06	0.000363	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PLA2G4A—breast cancer	4.02e-06	0.000363	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GPX1—breast cancer	3.85e-06	0.000348	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP1A1—breast cancer	3.81e-06	0.000345	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ERCC2—breast cancer	3.78e-06	0.000342	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTHFR—breast cancer	3.55e-06	0.000321	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CAV1—breast cancer	3.28e-06	0.000296	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CG—breast cancer	2.98e-06	0.00027	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CD—breast cancer	2.62e-06	0.000237	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ALB—breast cancer	2.59e-06	0.000234	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NOS3—breast cancer	2.48e-06	0.000224	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CB—breast cancer	2.29e-06	0.000207	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTGS2—breast cancer	2.27e-06	0.000205	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTEN—breast cancer	1.98e-06	0.000179	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CA—breast cancer	1.39e-06	0.000126	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AKT1—breast cancer	1.14e-06	0.000103	CbGpPWpGaD
